The final provisions for The Sunshine Act, which requires pharmaceutical and medical device manufacturers to track and publicly report what they spend on physicians at their meetings, were released February 1. Under the final rule, companies and GPOs will be required to begin collected data on August 1, 2013. The data collected from August – December 2013 will be posted publicly on the Centers for Medicare & Medicaid Services website in September 2014.

Since Meeting Logistics has been planning meetings for 13 years for pharmaceutical, bioscience, medical device, and other life sciences, we attended the Pharma Forum 2013 for updates, education and networking. Daniel J. Garen, Senior VP and Chief Compliance Officer, Wright Medical Technology, Inc. gave the keynote on the implications of the final rulings of the Sunshine Act on Pharma and Life Sciences meetings. Other presentations and panels included topics such as Best Practices, What companies need to know to plan internal meetings and meetings for healthcare professionals that are effective and compliant with the PhRMA and AdvaMed Codes, the Sunshine Act, and State laws, Innovation and Technology, Virtual Meetings verses Face to Face and Pharma/Hotel Contract Insight from Steven Rudner, Esq., Rudner Law Offices.

Many of us agreed that Pharma planners are chameleons! We provide enormous value with upfront planning and logistics guidance within a highly regulated healthcare environment. Interested in more info on the Sunshine Act? Check out this article.